ECENT insights into the molecular pathophysiological mechanisms of disease and injury to the central and peripheral nervous systems have led to the development of many potentially therapeutic macromolecules. However, the therapeutic efficacy and clinical use of these compounds has been limited by problems associated with currently available delivery techniques. Existing methods of drug delivery to peripheral nerves include systemic administration and local application. Various routes of systemic delivery that have been tried include subcutaneous, intravenous, and intramuscular injection. Clinically, the use of systemic delivery has been limited by toxicity resulting from the large doses necessary to obtain therapeutic levels at the desired site, the short halflife of many compounds in the systemic circulation, and antibody formation. Although the direct application of therapeutic agents to the site of nerve injury avoids some of the problems associated with systemic delivery, this delivery method is limited by poor epineurial penetration, inability to provide multiple doses of drug, and limited longitudinal distribution along the nerve by an exponential drop in concentration associated with diffusion.
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Object. Although many macromolecules have treatment potential for peripheral nerve disease, clinical use of these agents has been restricted because of limitations of delivery including systemic toxicity, heterogeneous dispersion, and inadequate distribution. In an effort to overcome these obstacles, the authors examined the use of convection to deliver and distribute macromolecules into peripheral nerves.
Methods. For convective delivery, the authors used a gas-tight, noncompliant system that provided continuous flow through a small silica cannula (inner diameter 100 m, outer diameter 170 m) inserted into a peripheral nerve. Increases in the volume of infusion (Vi) (10, 20, 30, 40 , and 80 l) of 14 C-labeled (nine nerves) or gadolinium-labeled (two nerves) albumin were infused unilaterally or bilaterally into the tibial nerves of six primates (Macaca mulatta) at 0.5 l/minute. The volume of distribution (Vd), percentage recovery, and delivery homogeneity were determined using quantitative autoradiography, an imaging program developed by the National Institutes of Health, magnetic resonance (MR) imaging, scintillation counting, and kurtosis (K) analysis. One animal that was infused bilaterally with gadolinium-bound albumin (40 l to each nerve) underwent MR imaging and was observed for 16 weeks after infusion.
The Vd increased with the Vi in a logarithmic fashion. The mean Vd/Vi ratio over all Vi was 3.7 Ϯ 0.8 (mean Ϯ standard deviation). The concentration across the perfused region was homogeneous (K = Ϫ1.07). The infusate, which was limited circumferentially by the epineurium, followed the parallel arrangement of axonal fibers and filled long segments of nerve (up to 6.8 cm). Recovery of radioactivity was 75.8 Ϯ 9%. No neurological deficits arose from infusion.
Conclusions. Convective delivery of macromolecules to peripheral nerves is safe and reliable. It overcomes obstacles associated with current delivery methods and allows selective regional delivery of putative therapeutic agents to long sections of nerve. This technique should permit the development of new treatments for numerous types of peripheral nerve lesions.
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can be used to enhance the delivery and distribution of macromolecules into the peripheral nervous system, we examined delivery of macromolecules by convection into the tibial nerves of primates.
Materials and Methods

Animal Model
Five adult primates (Macaca mulatta) received unilateral (one nerve) or bilateral (eight nerves) tibial nerve volume infusion (Vi) of 14 C-albumin solution in increasing amounts (10, 20, 30, 40 , and 80 l). The animals had been used in previous experiments and were infused with the 14 C-albumin before their scheduled deaths. A sixth animal had both tibial nerves infused with gadolinium (Gd)-albumin (40 l in each nerve).
All animal experiments were conducted in accordance with the National Institutes of Health (NIH) guidelines on the use of animals in research and approved by the National Institute of Neurological Disorders and Stroke Animal Care and Use and Radiation Safety Committees.
Infusion Apparatus
To distribute macromolecules into the peripheral nerve by means of convection, we developed a noncompliant delivery system that is gas-tight with no dead volume. 7 A syringe pump generates continuous pressure throughout an infusion, which is transmitted from the pump to a glass, gas-tight, infusate-filled Hamilton syringe by a hydraulic drive composed of water-filled polyetheretherketone (PEEK) tubing (inner diameter 0.02 in, outer diameter 0.062 in) attached at both ends to a 250-l gas-tight CX syringe. One CX syringe was placed in the syringe pump; the plunger of the other CX syringe transmitted the fluid pressure directly to the plunger of the infusate-filled syringe, resulting in delivery of infusate.
The infusion cannulae (inner diameter 100 m, outer diameter 170 m) were made of flexible fused silica and were secured into Teflon Leur fittings using epoxy glue. The Leur fitting was directly attached to the infusate syringe.
Administration of Infusate
Nine nerves were infused with 14 C-labeled (specific activity 0.024 mCi/mg) bovine serum albumin (69 kD; concentration 0.79 mg/ml) in a stock 0.01-M sodium phosphate buffer, pH 7.2, that was diluted in 10 ϫ phosphate-buffered saline ([PBS]; 9.8:1 per volume ratio); the final osmolarity was 280 to 290 mOsm. To visualize the infusion within the nerve, 4 l of Evan's blue dye (4.7 mg/ml in 1 ϫ PBS) was added to each 100 l of 14 C-albumin solution. For magnetic resonance (MR) imaging, one animal was infused with Gd-labeled human serum albumin. Each human serum albumin molecule was covalently linked via a lysine residue to 15 Gd and 10 biotin molecules (calculated 78 kD). 9 The stock solution was diluted in 1 ϫ PBS (1:15 per volume ratio).
Surgical Procedure
After anesthesia (ketamine 10 mg/kg and xylazine 0.5 mg/kg given intramuscularly) had been induced, the animals were intubated and maintained with 1 to 1.5% halothane general anesthesia. Heart rate, body temperature, oxygen saturation, and PCO 2 were monitored throughout the procedure. The animal was placed prone on a warming blanket and the posterior, medial, and lateral aspects of both lower extremities were prepared in an aseptic fashion. An 8-cm linear incision was made in the posterior midline of the thigh. Dissection was carried into the intramuscular septum to expose the peroneal and tibial nerves. The epineurium of the tibial nerve was incised, and the silica catheter was directed into the opening in the epineurium in a distal direction for 20 mm. The cannula was positioned with its tip in the center of the nerve. The cannula was secured to the epineurium with cyanoacrylate glue and was left in position for 70 minutes before starting the infusion to allow time for the nerve tissue to seal around it. All infusions were performed at 0.5 l/minute. At the completion of the infusion, the catheters were left in place for 15 additional minutes. The glue was then dissected from the epineurium and the cannula was removed. The animals infused with 14 C-albumin were killed by barbiturate overdose. The animal infused with Gd-albumin underwent MR imaging, was permitted to recover, and recieved careful neurological examination over a course of 16 weeks.
Determination of Volume of Distribution
After completion of the 14 C-albumin infusions, the infused segments of nerve were excised and immediately frozen at Ϫ70˚C. The nerves were serially cut in 20-m sections either cross sectionally (one nerve) or longitudinally (eight nerves). Every fifth section was exposed to autoradiographic film for 4 hours by using appropriate 14 C standards and developed. The autoradiographic images were scanned into a computer and the area (in square millimeters) of infusion was by measured using NIH Image software after a threshold of 15% of the maximum optical intensity over the infusion was used to determine the limits of measured infusion. The volume of distribution (Vd) was calculated by summing the derived areas and multiplying by 0.1 mm.
Determination of Percentage of Recovery of 14 C-Albumin
Two 20-m sections located between the longitudinal sections (six nerves) used for autoradiographic analysis were removed and placed into scintillation vials (20 ml) containing 5 ml scintillation fluid. A scintillation counter was used to determine counts per minute, which were converted to decays per minute using the sensitivity of the counter. Values for recovery of 14 C activity were derived by multiplying the total number of decays per minute in the sections by 2.5 and then dividing the product by the total expected activity calculated to be in the delivered infusate.
Determination of Infusion Homogeneity
Concentration profiles of radioactivity were determined along the longitudinal and cross-sectional dimensions in 0.03-mm increments and converted to an equivalent mass distribution value by using NIH Image software. These values were used to calculate the kurtosis (K) value by Equation 1 where X n is the nth moment of the longitudinal distribution. 7 (1)
For comparison purposes, we modeled the two limiting cases of albumin distribution in the nerve (modeled as a thin cylindrical rod):
3 pure axial diffusion and pure bulk flow. 7 To model the distribution by axial diffusion, we used a probability density function (p(x); Equation 2) based on the assumption that a mass delivered at the same rate as by infusion moves outward from a central plane in the rod solely by diffusion. The t 0 is identical to the total infusion time; x is the axial distance from the central plane; erfc is the complementary error function; and D is the albumin diffusion coefficient (D = 6.9 ϫ 10 Ϫ7 ) 11 in the extracellular space.
In the case of the thin cylindrical rod model of pure diffusion, the K value is 1. In contrast, pure bulk flow, described by a homogeneous square wave distribution, has a K value of Ϫ1.2.
Concentration profiles of radioactivity in the cross-sectional and longitudinal planes across the infusions were also determined in 0.04-mm increments and converted to an equivalent mass distribution by using NIH Image software and then plotted graphically.
Magnetic Resonance Imaging and Clinical Observation
After completion of the infusion of Gd-albumin, one animal immediately underwent MR imaging of the infused region. Coronal (slice thickness 2 mm) and axial (slice thickness 7 mm) T 1 -weighted images were obtained. The animal was awakened and extubated after the MR imaging session for immediate postoperative neurological examination. Neurological examinations were performed over a course of 16 weeks.
Sources of Supplies and Equipment
The syringe pump (model 22) was obtained from Harvard Apparatus (S. Natick, MA), and the Hamilton syringe, gas-tight syringe, PEEK tubing, and fused silica from Thompson Instruments (Springfield, MA). The 14 C-labeled bovine serum albumin solution was purchased from New England Nuclear (Beverly, MA). The cyanoacrylate glue (Vetbond Tissue Adhesive) was obtained from 3M (St. Paul, MN), the autoradiographic film (Biomax MR Film) from Eastman Kodak (Rochester, NY), and the carbon-14 standards from American Radiolabeled Chemicals (St. Louis, MO). The Image software program was developed by W. Rasband and is available from NIH (Bethesda, MD). Scintillation fluid was purchased from National Diagnostics (Atlanta, GA) for use with the scintillation counter (model LS6000SE) manufactured by Beckman (Fullerton, CA).
Results
Distribution of 14 C-Albumin
The Vd of 14 C-albumin increased with increasing Vi (Fig. 1) . The equation for the line followed a logarithmic function (R 2 = 0.99; Fig. 1 ). The Vd/Vi ratio decreased as the Vi increased, with a mean Vd/Vi ratio of 3.7 Ϯ 0.8 (mean Ϯ standard deviation; Table 1 ) and a range of 2.1 (Vi 80 l) to 4.6 (Vi 20 l). The distribution of the infusate, grossly as well as autoradiographically, was limited by the epineurium of the infused nerve and was parallel to the nerve fibers (Fig. 2) . This produced filling of long segments of nerve with infusate (6.8 cm in the nerve infused with 80 l). The longitudinal length (parallel to nerve fibers) of perfused nerve was linearly related to Vi (R 2 = 0.93; Fig. 3 left) , whereas the lateral and anteroposterior distributions were not (Fig. 3 center and right) .
Recovery of 14 C-Albumin
The mean radioactivity recovered from within the nerves at the various infusion volumes was 75.8 Ϯ 9% (Table 1 ). The lowest recovery of 14 C activity (62%) occurred in the nerve infused with 80 l.
Homogeneity of the 14 C-Albumin Infusion
The calculated K value for the experimental distribution of 14 C-albumin in the nerve was Ϫ1.07. This closely approximates the Ϫ1.2 value expected with a uniform square wave distribution generated by pure bulk flow. Consistent with the calculated K value, a square-shaped distribution profile of 14 C-albumin was measured across the region of infusion (Fig. 4) .
Magnetic Resonance Imaging and Clinical Findings
Magnetic resonance imaging of the animal in which 40 l of Gd-albumin was infused into each tibial nerve was consistent with findings seen with animals that received similar infusions of 14 C-albumin. The infusions were limited by the epineurium and distributed parallel to the nerve fibers, filling long segments (3.6 and 4 cm) of the nerve (Fig. 5) . No spillage of contrast-bound infusate outside the nerve was evident. No deficits were noted immediately after surgery or throughout an observation period lasting 16 weeks.
Discussion
Convective Delivery
Previously we showed that convective, or bulk flow, delivery to the central nervous system can be used successfully to distribute macromolecules homogeneously over a large Vd to precise regions in gray and white matter. 2, 5, 6, 8 Although the parameters of delivery in these regions of the central nervous system have been described, the feasibility and parameters of delivery in which convection in the peripheral nervous system is used are unknown. In this study, we examined convection-enhanced delivery of macromolecules to the peripheral nervous system and characterized the properties of bulk flow distribution in peripheral nerves. The Vd of 14 C-albumin infusate in peripheral nerves revealed that the Vd increased with increasing Vi and that the Vd/Vi ratio was 3.7 Ϯ 0.8. Although previous studies of convection in the central nervous system have demonstrated a linear relationship between Vd and Vi, 2, 6 we found a logarithmic association in peripheral nerve. This effect was most pronounced at higher infusion volumes (Table 1) . Possible explanations for this difference include: a higher rate of infusion than those used in the spinal cord infusions; 7 leakage back along the needle tract with a higher Vi (although this was not seen on MR imaging or quantitative autoradiography); decreased recovery of 14 C activity with a higher Vi; differences in the viscoelastic properties of the peripheral nerve as compared with the central nervous system; or diminished transmission of flow over greater distances, which may result in the maximum Vd being approached.
Consistent with convective distribution in the spinal cord, 14 C-albumin and Gd-albumin infusions in the peripheral nerve distributed preferentially along the longitudinal axis of nerve fibers. This likely reflects a path of lower resistance in the extracellular spaces surrounding fibers of passage previously noted in studies using convective delivery 2 and quantitative-diffusion-tensor MR imaging in the central nervous system. 1 Anatomically, the infusate distribution was limited by the epineurium, as demonstrated by gross visualization of Evan's blue staining, by autoradiographic analysis, which showed specific activity
J. Neurosurg. / Volume 89 / October, 1998
Convective delivery into peripheral nerves delineated by the epineurium, and as observed on MR imaging.
A high rate of infusate recovery (75.8 Ϯ 9%) occurred in animals infused with 14 C-albumin. The lowest percentage of recovery (62%) was in the animal infused with the largest volume of infusate (80 l). The lower rate of recovery in this animal may be due to loss of infusate secondary to leakage along the needle tract, which can occur with larger volumes or higher rates of infusion. The lower rate of recovery in peripheral nerves compared with the spinal cord 7 could be related to a multitude of factors including differences in the removal and handling of the nerve as well as the intrinsic properties of the nerve. Similar to other studies in which convection was used in the central nervous system, delivery of infusate in the peripheral nerve was homogeneous. Distribution homogeneity was determined by kurtosis analysis. Kurtosis is a statistic that is used to describe numerically the shape of a distribution curve. 12 Analysis of the concentration distribution across the region of infusion resulted in a K value of Ϫ1.07, which is close to the K value of Ϫ1.2 modeled for ideal bulk flow distribution. Moreover, the square- shaped concentration profile of radioactivity (Fig. 4) underscores the ability of this technique to deliver relatively uniform concentrations to specific regions, making it possible to target specific regions of nervous tissue selectively with uniform concentrations of infusate.
Magnetic resonance imaging in the region of the nerves infused with Gd-albumin corresponded closely with findings seen with 14 C-albumin infusions of the same volume. In the future, coinfusions of tracers and therapeutic agents could be used to monitor the extent and anatomical location of infusate over short or prolonged courses of treatment. Moreover, the infusion of 40 l Gd-albumin into each of the tibial nerves of a primate was well tolerated. No deficits were detected at any stage of the animal's 16-week postoperative course. This is consistent with other studies of bulk flow infusion within the brain 2, 6 and spinal cord. 7 
Potential Applications
The results of the current study indicate that with convective delivery large volumes of macromolecules can be delivered to peripheral nerves in a homogeneous, predictable, and reproducible fashion that permits precise delivery of pharmacological agents to specific targets over clinically significant volumes. These properties suggest that convection-enhanced delivery of large and small compounds to the intraneural space of peripheral nerves may have use in the research and treatment of conditions affecting central and peripheral nerves. Examples include prevention of intraneural scarring, attenuation of inappropriate apoptosis, delivery of factors to promote nerve regeneration, and maintenance of viability of the neuromuscular junction after nerve injury. Furthermore, the possibility exists of taking advantage of retrograde transport systems to gain access to specific regions of the spinal cord and higher cortical systems. Previous work has shown transneural transport of nucleic acids and other molecules after intraneuronal injection. 4, 10 Thus, intraneural convective delivery could provide a highly selective means of distributing therapeutic compounds to both peripheral and central nervous systems, while obviating the many systemic side effects and other delivery problems associated with these techniques.
Conclusions
Intraneural convective delivery of macromolecules provides homogeneous, targeted, reproducible, and safe distribution of infusate to peripheral nerves. This delivery method should provide new approaches for investigation and treatment of injuries and other disorders of the peripheral nervous system.
